Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

  0      
Direct Value   $18,063,061    

Indirect Value

  $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296 Onyx Pharmaceuticals Inc
 $0 Biomarin Pharmaceutical Inc
 $17,448,765 Mirati Therapeutics, Inc.
 $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-04-20 4 OE $11.05 $55,250 D/D 5,000 36,000 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-04-20 4 S $27.00 $355,455 D/D (13,165) 22,835 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-04-29 4 A $13.23 $21,426 D/D 1,620 24,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-05-12 4 A $0.00 $0 D/D 12,000 36,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-07-01 4 OE $11.05 $27,625 D/D 2,500 38,955 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-07-01 4 AS $27.68 $69,200 D/D (2,500) 36,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-07-14 4 OE $11.05 $55,250 D/D 5,000 41,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-07-14 4 AS $30.00 $150,000 D/D (5,000) 36,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-10-03 4 OE $11.05 $27,625 D/D 2,500 38,955 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-10-03 4 AS $31.00 $77,507 D/D (2,500) 36,455 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2011-10-31 4 A $13.23 $2,063 D/D 156 36,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-01-03 4 OE $11.05 $27,625 D/D 2,500 39,111 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-01-03 4 AS $34.75 $86,883 D/D (2,500) 36,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-02 4 OE $11.05 $55,250 D/D 5,000 41,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-02 4 AS $34.08 $170,380 D/D (5,000) 36,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-20 4 AS $35.00 $269,185 D/D (7,691) 28,920 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-30 4 A $19.35 $21,242 D/D 1,098 30,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-01 4 OE $11.05 $55,250 D/D 5,000 35,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-01 4 AS $34.99 $174,950 D/D (5,000) 30,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-08 4 A $0.00 $0 D/D 24,000 54,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-12 5 D $0.00 $0 D/D (1,101) 46,497 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-06-01 4 AS $35.02 $175,078 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-06-01 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-07-02 4 OE $11.05 $165,750 D/D 15,000 67,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-07-02 4 AS $40.00 $602,808 D/D (15,000) 52,277 0 -

  294  Records found
  1   2   3   4   5   6  7   8   9   10   11   12      
  Page 6 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed